Related Experiment Video

Updated: Jun 1, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Oncogenic alterations in primary human lung-tumors (review)

K Strebhardt1, U Holtrich, A Brauninger

  • 1GEORG SPEYER HAUS,CHEMOTHERAPEUT FORSCHUNGSINST,D-60596 FRANKFURT,GERMANY. KRANKENHAUS NW FRANKFURT,GEFASS & THORAXCHIRURG KLIN,D-60488 FRANKFURT,GERMANY.

Oncology Reports
|May 25, 2011
PubMed

Insights

Understanding lung cancer mechanisms is crucial for better diagnosis and treatment. This study identifies key genetic alterations, including chromosomal changes and mutations in oncogenes and tumor suppressor genes, involved in lung carcinoma development.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Lung cancer is a leading cause of cancer death globally.
  • Understanding the molecular mechanisms of lung cancer is vital for improved diagnosis and therapy.
  • Specific genetic alterations are implicated in lung carcinoma development.

Purpose of the Study:

  • To investigate the genetic aberrations associated with primary lung cancer.
  • To identify key genes and chromosomal regions involved in lung cancer pathogenesis.
  • To explore the role of growth factors and their receptors in lung tumor development.

Main Methods:

  • Analysis of primary lung cancer samples.
  • Examination of chromosomal alterations and allelic losses.
  • Assessment of genetic aberrations in proto-oncogenes and tumor suppressor genes.
  • Evaluation of gene expression, including growth factors and receptors.

Main Results:

  • Specific chromosomal alterations and allelic losses on the short arm of chromosome 3 were identified.
  • Genetic aberrations were observed in proto-oncogenes (H-ras, K-ras, C-myc, raf-1) and tumor suppressor genes (Rb, p53).
  • Rearrangement of the rlf gene and altered expression of growth factor genes (TGF beta 2) and receptor genes (c-erbB-2, HEK2, FGFR-4) were reported.

Conclusions:

  • Genetic aberrations, including chromosomal changes and mutations in key oncogenes and tumor suppressor genes, play a significant role in lung cancer development.
  • Altered expression of growth factors and their receptors are implicated in the pathogenesis of lung carcinoma.
  • Further research into these genetic mechanisms can lead to improved diagnostic and therapeutic strategies for lung cancer.

More Related Videos

Optimized Preparation of Whole Murine Tumor-Bearing Lung Tissue for Flow Cytometry and Single-Cell RNA-Sequencing06:44

Optimized Preparation of Whole Murine Tumor-Bearing Lung Tissue for Flow Cytometry and Single-Cell RNA-Sequencing

Published on: May 22, 2026

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...